RhumbLine Advisers’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.92M | Buy |
165,539
+45,049
| +37% | +$522K | ﹤0.01% | 1909 |
|
|
2025
Q1 | $1.05M | Buy |
120,490
+12,374
| +11% | +$108K | ﹤0.01% | 2149 |
|
|
2024
Q4 | $1.55M | Sell |
108,116
-1,641
| -1% | -$23.6K | ﹤0.01% | 2016 |
|
|
2024
Q3 | $2.48M | Buy |
109,757
+2,785
| +3% | +$62.9K | ﹤0.01% | 1792 |
|
|
2024
Q2 | $2.08M | Buy |
106,972
+65
| +0.1% | +$1.26K | ﹤0.01% | 1859 |
|
|
2024
Q1 | $4.01M | Sell |
106,907
-14,975
| -12% | -$562K | ﹤0.01% | 1535 |
|
|
2023
Q4 | $6.82M | Buy |
121,882
+475
| +0.4% | +$26.6K | 0.01% | 1245 |
|
|
2023
Q3 | $5.01M | Buy |
121,407
+718
| +0.6% | +$29.6K | 0.01% | 1344 |
|
|
2023
Q2 | $6.74M | Buy |
120,689
+12,321
| +11% | +$688K | 0.01% | 1208 |
|
|
2023
Q1 | $6.05M | Buy |
108,368
+7,039
| +7% | +$393K | 0.01% | 1216 |
|
|
2022
Q4 | $3.69M | Buy |
101,329
+5,775
| +6% | +$210K | 0.01% | 1454 |
|
|
2022
Q3 | $2.72M | Buy |
95,554
+10,920
| +13% | +$311K | ﹤0.01% | 1604 |
|
|
2022
Q2 | $3.83M | Buy |
84,634
+13,457
| +19% | +$609K | 0.01% | 1398 |
|
|
2022
Q1 | $5.41M | Sell |
71,177
-7,521
| -10% | -$572K | 0.01% | 1257 |
|
|
2021
Q4 | $11.7M | Buy |
78,698
+2,607
| +3% | +$388K | 0.01% | 904 |
|
|
2021
Q3 | $11.1M | Sell |
76,091
-749
| -1% | -$109K | 0.02% | 897 |
|
|
2021
Q2 | $15M | Buy |
76,840
+19,354
| +34% | +$3.79M | 0.02% | 764 |
|
|
2021
Q1 | $10.4M | Sell |
57,486
-1,109
| -2% | -$201K | 0.01% | 964 |
|
|
2020
Q4 | $8.3M | Sell |
58,595
-349
| -0.6% | -$49.4K | 0.01% | 1047 |
|
|
2020
Q3 | $7.35M | Sell |
58,944
-1,282
| -2% | -$160K | 0.01% | 932 |
|
|
2020
Q2 | $5.38M | Buy |
+60,226
| New | +$5.38M | 0.01% | 1169 |
|